ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Pledge
|
114 |
29K |
5 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
114
|
29K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Chair Transition
|
|
Pledge
|
18 |
6.8K |
5 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
18
|
6.8K
|
5
|
|
ASX - By Stock
|
AC8 |
Re:
AC8 Moving Forward - 2024
|
|
Pledge
|
170 |
60K |
8 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
170
|
60K
|
8
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Recruitment Completed in Phase 3 OA Clinical Trial
|
|
Pledge
|
7 |
2.5K |
4 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
7
|
2.5K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Ann: DFU Clinical Trial Enrolment Complete
|
|
Pledge
|
22 |
5.4K |
2 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
22
|
5.4K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: DFU Clinical Trial Enrolment Complete
|
|
Pledge
|
22 |
5.4K |
2 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
22
|
5.4K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: DFU Clinical Trial Enrolment Complete
|
|
Pledge
|
22 |
5.4K |
2 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
22
|
5.4K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: DFU Clinical Trial Enrolment Complete
|
|
Pledge
|
22 |
5.4K |
1 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
22
|
5.4K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: DFU Clinical Trial Enrolment Complete
|
|
Pledge
|
22 |
5.4K |
2 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
22
|
5.4K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Pledge
|
133 |
45K |
1 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
133
|
45K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Pledge
|
133 |
45K |
1 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
133
|
45K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Pledge
|
133 |
45K |
4 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
133
|
45K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Pledge
|
133 |
45K |
0 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
133
|
45K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Pledge
|
133 |
45K |
5 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
133
|
45K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Pledge
|
133 |
45K |
2 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
133
|
45K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Pledge
|
133 |
45K |
2 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
133
|
45K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Pledge
|
133 |
45K |
0 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
133
|
45K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Pledge
|
133 |
45K |
0 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
133
|
45K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Pledge
|
133 |
45K |
3 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
133
|
45K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Pledge
|
133 |
45K |
5 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
133
|
45K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Pledge
|
133 |
45K |
5 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
133
|
45K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Pledge
|
133 |
45K |
2 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
133
|
45K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Pledge
|
9.5K |
2.8M |
3 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
9.5K
|
2.8M
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Ann: First Patient Treated in Phase 2 GvHD Trial
|
|
Pledge
|
61 |
11K |
1 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
61
|
11K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Pledge
|
5.1K |
2.5M |
0 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Pledge
|
5.1K |
2.5M |
1 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Pledge
|
5.1K |
2.5M |
0 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
5.1K
|
2.5M
|
0
|
|
ASX - By Stock
|
SYR Graphite |
Re:
General Discussion
|
|
Pledge
|
1.1K |
450K |
1 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
1.1K
|
450K
|
1
|
|
ASX - By Stock
|
SYR Graphite |
Re:
General Discussion
|
|
Pledge
|
1.1K |
450K |
0 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
1.1K
|
450K
|
0
|
|
ASX - By Stock
|
SYR Graphite |
Re:
General Discussion
|
|
Pledge
|
1.1K |
450K |
2 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
1.1K
|
450K
|
2
|
|
ASX - By Stock
|
SYR Graphite |
Re:
General Discussion
|
|
Pledge
|
1.1K |
450K |
2 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
1.1K
|
450K
|
2
|
|
ASX - By Stock
|
SYR Graphite |
Re:
General Discussion
|
|
Pledge
|
1.1K |
450K |
3 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
1.1K
|
450K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
Pledge
|
554 |
223K |
5 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
554
|
223K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
Pledge
|
554 |
223K |
7 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
554
|
223K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Placement and Entitlement Offer
|
|
Pledge
|
154 |
46K |
2 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
154
|
46K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Pledge
|
551 |
199K |
2 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
551
|
199K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Pledge
|
551 |
199K |
0 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
551
|
199K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Pledge
|
551 |
199K |
2 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
551
|
199K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Pledge
|
551 |
199K |
8 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
551
|
199K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Pledge
|
551 |
199K |
2 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
551
|
199K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Pledge
|
551 |
199K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
551
|
199K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Pledge
|
551 |
199K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
551
|
199K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Pledge
|
551 |
199K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
551
|
199K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Pledge
|
551 |
199K |
3 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
551
|
199K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Pledge
|
551 |
199K |
2 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
551
|
199K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Pledge
|
551 |
199K |
3 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
551
|
199K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Pledge
|
551 |
199K |
2 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
551
|
199K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Pledge
|
551 |
199K |
5 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
551
|
199K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
Pledge
|
590 |
221K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
590
|
221K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
Pledge
|
590 |
221K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
590
|
221K
|
0
|
|